Adaptations to iron deficiency: Cardiac functional responsiveness tonorepinephrine, arterial remodeling, and the effect of beta-blockade oncardiachypertrophy

BMC Physiology

Volumn 2, Issue , 2002, Pages 1-10

  Turner, Lexa Rae ^a   Premo, Daniel Aaron ^a   Gibbs, Brett Jason ^a   Hearthway, Megan Lesley ^a   Motsko, Madelyne ^a   Sappington, Andrea ^a   Walker, LeeAnn ^a   Mullendore, Michael Eugene ^a   Chew Jr , Herbert George ^a  

^a SALISBURY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; NORADRENALIN; PROPRANOLOL; IRON;

ABDOMINAL AORTA; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTERY COMPLIANCE; ARTERY DIAMETER; ARTICLE; BODY MASS; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; HEART MUSCLE CONTRACTILITY; HEART RATE; HEART VENTRICLE HYPERTROPHY; HEART WEIGHT; HEMATOCRIT; IRON DEFICIENCY; MALE; NONHUMAN; RAT; SYSTOLIC BLOOD PRESSURE; ADAPTATION; ANIMAL; ARTERY; BODY WEIGHT; CARDIOMEGALY; ELASTICITY; HEART; HEART CONTRACTION; HEART MUSCLE; HEMODYNAMICS; ORGAN SIZE; PATHOLOGY; PATHOPHYSIOLOGY;

ADAPTATION, PHYSIOLOGICAL; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; ARTERIES; BODY WEIGHT; CARDIOMEGALY; ELASTICITY; HEART; HEART RATE; HEMATOCRIT; HEMODYNAMIC PROCESSES; IRON; MALE; MYOCARDIAL CONTRACTION; MYOCARDIUM; NOREPINEPHRINE; ORGAN SIZE; PROPRANOLOL; RATS;

EID: 0642336978     PISSN: 14726793     EISSN: None     Source Type: Journal    
DOI: 10.1186/1472-6793-2-1     Document Type: Article

References (69)

1. Sullivan JL: Iron and the sex difference in heart disease risk. Lancet 1981, 1:1293
2. Williams RE, Zweier JL, Flaherty JT: Treatment with deferoxamine during ischemia improves functional and metabolic recovery and reduces reperfusion-induced oxygen radical generation in rabbit hearts. Circulation 1991, 83:1006
3. van der Kraaij AMM, Mostert LJ, van Eijk HG, Koster JF: Iron-load increases the susceptibility of rat hearts to oxygen reper-fusion damage: Protection by the antioxidant (+)- cyanidanol-3 and deferoxamine. Circulation 1988, 78:442
4. Roest M, van der Schouw TT, de Valk B, Marx JJM, Tempelman MJ, de Groot PG, Sixma JJ, Dirk Banga J: Heterozygosity for a heriditary hemochromatosis gene is associated with cardiovascular death in women. Circulation 1999, 100:1268
5. Tuomainen T-P, Kontula K, Nyyssönen K, Lakka TA, Heliö T, Salonen JT: Increased risk of acute myocardial infarction in carriers of the hemochromatosis gene cys282tyr mutation. Circulation 1999, 100:1274
6. Ascherio A, Rimm EB, Giovannucci E, Willett WC, Stampfer MJ: Blood donations and risk of coronary heart disease in men. Circulation 2001, 103:52
7. McCord JM: Is iron sufficiency a risk factor in ischemic heart disease? Circulation 1991, 83:1112
8. Sullivan JL: Iron and the genetics of cardiovascular disease. Circulation 1999, 21:1260
9. Sullivan JL: Iron therapy and cardiovascular disease. Kidney Int Suppl 1999, 69:S135
10. Sullivan JL: Misconceptions in the debate on the iron hypothesis. J Nutr Biochem 2001, 12:33
11. Rossi MA, Carillo SV: Electron microscopic study on the cardiac hypertrophy induced by iron deficiency anaemia in the rat. Br J Exp Pathol 1983, 64:373
12. Rossi MA, Carillo SV: Pathogenesis of cardiac hypertrophy in iron deficiency anaemia: the role of noradrenaline. Br J Exp Pathol 1982, 63:269
13. Rossi MA, Carillo SV, Oliveira JSM: The effect of iron deficiency anemia in the rat on catecholamine levels and heart morphology. Cardiovas Res 1981, 15:313
14. Tanne Z, Coleman R, Nahir M, Shomrat D, Finberg JPM, Youdim MBH: Ultrastructural and cytochemical changes in the heart of iron-deficient rats. Biochem Pharmacol 1994, 47:1759
15. Olivetti G, Lagrasta C, Quaini F, Ricci R, Moccia G, Caprasso JM, Anversa P: Capillary growth in anemia-induced ventricular wall remodeling in the rat heart. Circ Res 1989, 65:1182
16. Olivetti G, Quaini F, Lagrasta C, Ricci R, Tiberti G, Capasso JM, Anversa P: Myocyte cellular hypertrophy and hyperplasia contribute to ventricular wall remodeling in anemia-induced cardiac hypertrophy in rats. Am J Pathol 1992, 141:227
17. Medeiros DM, Beard JL: Dietary iron deficiency results in cardiac eccentric hypertrophy in rats. Proc Soc Exp Biol Med 1998, 218:370
18. Whittaker P, Mahoney AW, Hendricks DG: Effect of iron-deficiency anemia on percent blood volume in growing rats. J Nutr 1984, 114:1137
19. Dillman E, Johnson DG, Martin J, Mackler B, Finch CA: Catecholamine elevation in iron deficiency. Am J Physiol 1979, 237:R297
20. Beard JL, Tobin BW, Smith SM: Effects of iron repletion and correction of anemia on norepinephrine turnover and thyroid metabolism in iron deficiency. Proc Soc Exp Biol Med 1990, 193:306
21. Beard JL, Tobin B, Smith SM: Norepinephrine turnover in iron deficiency, at three environmental temperatures. Am J Physiol 1988, 255:R90
22. Borel MJ, Smith SH, Brigham DE, Beard JL: The impact of varying degrees of iron nutriture on several functional consequences of iron deficiency in rats. J Nutr 1991, 121:729
23. Rossi MA, Carillo SV: Does norepinephrine play a central causative role in the process of cardiac hypertrophy? Am Heart J 1985, 109:622
24. Zelis R, Clemson B, Baily R, Davis D: Regulation of tissue noradrenaline in the rat myocardial infarction model of chronic heart failure. Cardiovasc Res 1992, 26:933
25. Daly PA, Sole MJ: Myocardial catecholamines and the pathophysiology of heart failure. Circulation 1990, 82:1-35
26. Hammond HK, Roth DA, Insel PA, Ford CE, White FC, Maisel AS, Ziegler MG, Bloor CM: Myocardial beta-adrenergic receptor expression and signal transduction after chronic volume-overload hypertrophy and circulatory congestion. Circulation 1992, 85:269
27. Kouchi I, Zolk O, Jockenhovel F, Itter G, Linz W, Cremers B, Bohm M: Increase in G(i alpha) protein accompanies progression of post-infarction remodeling in hypertensive cardiomyopathy. Hypertension 2000, 36:42
28. Schafer M, Frischkopf K, Taimor G, Piper HM, Schulter KD: Hypertrophic effect of selective beta(1)-adrenoceptor stimulation on ventriculat cardiomyocytes from adult rat. Am J Physiol Cell Physiol 2000, 279:C495
29. Zuo P, Izawa H, Ishiki R, Noda A, Nishizawa T, Shigemura K, Nagata K, Iwase M, Yokota M: Different beta-adrenergic regulation of myocardial contraction and relaxation between apical and nonobstructive hypertrophic cardiomyopathy. Am Heart J 2000, 140:329
30. Pei J, Yu X, Fung M, Zhou J, Cheung C, Wong N, Leung M, Wong T: Impaired G(s)alpha and adenylyl cyclase cause beta-adrenoceptor desensitization in chronically hypoxic rat hearts. Am J Physiol Cell Physiol 2000, 279:C1455
31. Du X, Gao X, Jennings G, Dart A, Woodcock E: Preserved ventricular contractility in infarcted mouse heart overexpressing beta(2)-adrenergic receptors. Am J Physiol Heart Circ Physiol 2000, 279:H2456
32. Nagata K, Communal C, Lim C, Jain M, Suter T, Eberli F, Satoh N, Colucci W, Apstein C, Liao R: Altered beta-adrenergic signal transduction in nonfailing hypertrophied myocytes from Dahl salt-sensitive rats. Am J Physiol Heart Circ Physiol 2000, 279:H2502
33. Akers W, Cross A, Speth R, Dwoskin L, Cassis L: Renin-angiotensin system and sympathetic nervous system in cardiac pressure-overload hypertrophy. Am J Physiol Heart Circ Physiol 2000, 279:H2797
34. Lin F, Owens WA, Chen S, Stevens ME, Kesteven S, Arthur JF, Woodcock EA, Fenely MP, Graham RM: Targeted alpha(1A)-adrenergic receptor overexpression induces enhanced cardiac contractility but not hypertrophy. Circ. Res. 2001, 89:343
35. Iaccarino G, Keys J, Rapacciuolo A, Shotwell K, Lefkowitz R, Rockman H, Koch W: Regulation of myocardial betaARK1 expression in catecholamine-induced cardiac hypertrophy in trangenic mice overexpressing alpha1B-adrenergic receptors. J Am Coll Cardiol 2001, 38:534
36. Ostman-Smith I: Cardiac sympathetic nerves as the final common pathway in induction of adaptive cardiac hypertrophy. Clin Sci 1981, 61:265
37. Varat M, Adolph R, Fowler N: Cardiovascular effects of anemia. Am Heart J 1972, 83:415
38. Kamiya A, Togawa T: Adaptive regulation of wall shear stress to flow change in the canine carotid artery. Am J Physiol Heart Circ 1980, 239:H14
39. O'Dell B: Roles for iron and copper in connective tissue biosynthesis. Philos Trans R Soc Lond B Biol Sci 1981, 14:91
40. Chvapil M, Hurych J, Ehrilchova E: The effect of iron deficiency on the synthesis of collagenous and non-collagenous proteins in wound granulation tissue and in the heart of rats. Exp Med Surg 1968, 26:52
41. Pettersen JC, Morrissey RL, Saunders DR, Pavkov KL, 3rd LLG, Turnier JC, Matheson DW, Schwartz DR: A 2-year comparison study of Crl:CD Br and Hsd:Sprague-Dawley SD rats. Fundam Appl Toxicol 1996, 33:196
42. Klinger MM, MacCarter GD, Boozer CN: Body weight and composition in the Sprague Dawley rat: comparison of three outbred sources. Lab Anim Sci 1996, 46:67
43. Jenkins JE, Medieros DM: Diets containing corn oil, coconut oil, and cholesterol alter ventricular hypertrophy, dilatation and function in hearts of rats fed copper-deficient diets. J Nutr 1993, 123:1150
44. Homcy C, Vatner S, Vatner D: Beta-adrenergic receptor regulation in the heart in pathophysiologic states: abnormal adrenergic responsiveness in cardiac disease. Ann Rev Physiol 1991, 53:137
45. Patel M, Stewart J, Loud A, Anversa P, Wang J, Fiegel L, Hintze T: Altered function and structure of the heart in dogs with chronic elevation in plasma norepinephrine. Circulation 1991, 84:2091
46. Engelhardt S, Hein L, Weismann F, Lohse MJ: Progressive hypertrophy and heart failure n beta1-adrenergic receptor transgenic mice. Proc Natl Acad Sci USA 1999, 96:7059
47. Mukherjee R, Spinale FG: L-type calium channel abundance and function with cardiac hypertrophy and failure: a review. J Mol Cell Cardiol 1998, 30:1899
48. Tse J, Huang MW, Leone RJ, Weiss HR, He YQ, Scholz PM: Down regulation of myocardial beta1-adrenoreceptor signal transduction system in pacing-induced failure in dogs wih aortic stenosis-induced left ventricular hypertrophy. Mol Cell Biochem 2000, 205:67
49. Sheridan DJ, Auteltano DJ, Wang B, Percy E, Woodcock EA, Du XJ: Beta2-adrenergic receptor overexpression driven by alpha-MHC promoter is downregulated in hypertrophied and failing myocardium. Cardiovasc Res 2000, 47:133
50. Furchgott RF: Role of endothelium in responses in vascular smooth muscle. Circ Res 1983, 53:557
51. Langille BL, O'Donnell F: Reductions in arterial diameter produced by chronic decreases in blood flow are endothelium-dependent. Science 1986, 231:405
52. Langille BL, Bendeck MP, Keeley FW: Adaptations of carotid arteries of young and mature rabbits to reduced carotid blood flow. AJP 1989, 256:H931
53. Miller VM, Vanhoutte PM: Enhanced release of endothelium-derived factor(s) by chronic increases in blood flow. Am J Physiol 1988, 255:H446
54. Guyton JR, Hartley CJ: Flow restriction of one carotid artery in juvenile rats inhibits growth of arterial diameter. Am J Physiol 1985, 248:H540
55. Palmer RMJ, Ferrige AG, Moncada S: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987, 327:524
56. Cho MC, A R, Koch WJ, Kobayashi Y, LR J, Rockman HA: Defective beta-adrenergic receptor signaling precedes the development of dilated cardiomyopathy in transgenic mice with calsequestrin overexpression. J Biol Chem 1999, 274:22251
57. Calls J, Cases A, S. L, N. E, Pare JC, M. A, Jimenez W, F. R-F: Beta-adrenergic receptor density and function in left ventricular hypertrophy in young essential hypertensives. J Hum Hypertens 2000, 14:17
58. Barth W, Denten A, Bauer M, Reinohs M, Leicht M, Zimmer HG: Differential remodeling of the left and right heart after nore-pinephrine treatment in rats: studies on cytokines and collagen. J Mol Cell Cardiol 2000, 32:273
59. Xu X, Rials SJ, Wu Y, Liu T, Marinchak RA, Kowey PR: Effects of captopril treatment of renovascular hypertension on beta-adrenergic modulation of L-type Ca(2+) current. J Pharmacol Exp Ther 2000, 292:196
60. Communal C, Ribuot C, Durand A, Demenge P: Myocardial beta-adrenergic reactivity in volume overload-induced cardiac hypertrophy in the rat. Fundam Clin Pharmacol 1998, 12:411
61. Communal C, Ribuot C, Durand A, Demenge P: Myocardial beta-adrenergic reactivity in pressure overload-induced cardiac hypertrophy in the rat. Fundam Clin Pharmacol 1998, 12:590
62. Leon-Velarde F, Bourin MC, Germack R, Mohammadi K, Crozatier B, Richalet JP: Differential alterations in cardiac adrenergic signaling in chronic hypoxia or norepinephrine infusion. Am J Physiol Regul Integr Comp Physiol 2001, 280:R274
63. Schotten U, Filzmaier K, Borghardt B, Kulka S, Schoendube F, Schmacher C, Hanrath P: Changes of beta-adrenergic signaling in compensted human cardiac hypertrophy depend on the underlying disease. Am J Physiol Heart Circ Physiol 2000, 278:H2076
64. Schluter KD, Frischkopf K, Flesch M, Rosenkranz S, Taimor G, Piper HM: Central role for ornithine decarboxylase in beta-adrenoreceptor mediated hypertrophy. Cardiovasc Res 2000, 45:410
65. Martinez ML, Fernandez-Tome P, Lopez-Miranda V, Colado MI, Delgado C: Modulation of adrenergic receptors during left ventricular hypertrophy development after regression by captopril. J Cardiovasc Pharmacol 1999, 127:1012
66. Meissner A, Min JY, Simon R: Effects of angiotensin II on intropy and intracellular Ca2+ handling in normal and hypertrophied rat myocardium. J Mol Cell Cardiol 1998, 30:2507
67. Grimm D, Holmer SR, Riegger GA, Kromer EP: Effects of beta-receptor blockade and angiotensin II type I receptor antagonism in isoproterenol-induced heart failure. Cardiovas Pathol 1999, 8:315
68. Dallman PR, Refino CA, Yland MJ: Sequence of development of iron deficiency in the rat. Am J Clin Nutr 1982, 35:671
69. Reeves PG, Nielsen FH, Fahey GCJ: AIN-93 purified diets for laboratory rodents: Final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 1993, 123:1939